Anti-hypertensive drugs have different effects on ventricular hypertrophy regression
Autor(a) principal: | |
---|---|
Data de Publicação: | 2010 |
Outros Autores: | , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
Texto Completo: | http://dx.doi.org/10.1590/S1807-59322010000700012 http://repositorio.unifesp.br/handle/11600/5488 |
Resumo: | OBJECTIVES: There is a direct relationship between the regression of left ventricular hypertrophy (LVH) and a decreased risk of mortality. This investigation aimed to describe the effects of anti-hypertensive drugs on cardiac hypertrophy through a meta-analysis of the literature. METHODS: The Medline (via PubMed), Lilacs and Scielo databases were searched using the subject keywords cardiac hypertrophy, antihypertensive and mortality. We aimed to analyze the effect of anti-hypertensive drugs on ventricle hypertrophy. RESULTS: The main drugs we described were enalapril, verapamil, nifedipine, indapamina, losartan, angiotensin-converting enzyme inhibitors and atenolol. These drugs are usually used in follow up programs, however, the studies we investigated used different protocols. Enalapril (angiotensin-converting enzyme inhibitor) and verapamil (Ca++ channel blocker) caused hypertrophy to regress in LVH rats. The effects of enalapril and nifedipine (Ca++ channel blocker) were similar. Indapamina (diuretic) had a stronger effect than enalapril, and losartan (angiotensin II receptor type 1 (AT1) receptor antagonist) produced better results than atenolol (selective β1 receptor antagonist) with respect to LVH regression. CONCLUSION: The anti-hypertensive drugs induced various degrees of hypertrophic regression. |
id |
UFSP_b3a8754b0f90aeee03ec438c05f08cfb |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/5488 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Anti-hypertensive drugs have different effects on ventricular hypertrophy regressionHypertrophyCardiomyopathyHypertrophicLeft ventricle hypertensionCardiologyOBJECTIVES: There is a direct relationship between the regression of left ventricular hypertrophy (LVH) and a decreased risk of mortality. This investigation aimed to describe the effects of anti-hypertensive drugs on cardiac hypertrophy through a meta-analysis of the literature. METHODS: The Medline (via PubMed), Lilacs and Scielo databases were searched using the subject keywords cardiac hypertrophy, antihypertensive and mortality. We aimed to analyze the effect of anti-hypertensive drugs on ventricle hypertrophy. RESULTS: The main drugs we described were enalapril, verapamil, nifedipine, indapamina, losartan, angiotensin-converting enzyme inhibitors and atenolol. These drugs are usually used in follow up programs, however, the studies we investigated used different protocols. Enalapril (angiotensin-converting enzyme inhibitor) and verapamil (Ca++ channel blocker) caused hypertrophy to regress in LVH rats. The effects of enalapril and nifedipine (Ca++ channel blocker) were similar. Indapamina (diuretic) had a stronger effect than enalapril, and losartan (angiotensin II receptor type 1 (AT1) receptor antagonist) produced better results than atenolol (selective β1 receptor antagonist) with respect to LVH regression. CONCLUSION: The anti-hypertensive drugs induced various degrees of hypertrophic regression.Faculdade de Medicina do ABC Disciplina de Cardiologia Departamento de Clínica MédicaFaculdade de Medicina do ABC Departamento de Morfologia e FisiologiaUniversidade Federal de São Paulo (UNIFESP) Disciplina de Cardiologia Departamento de MedicinaUniversidade Estadual Paulista Faculdade de Ciências e Tecnologia Departamento de FisioterapiaUNIFESP, Disciplina de Cardiologia Depto. de MedicinaSciELOFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Nucleo de Estudos, Pesquisas e Assessoria a Saude da Faculdade de Medicina do ABC (NEPAS)Faculdade de Medicina / USPFaculdade de Medicina do ABC Disciplina de Cardiologia Departamento de Clínica MédicaFaculdade de Medicina do ABC Departamento de Morfologia e FisiologiaUniversidade Federal de São Paulo (UNIFESP)Universidade Estadual Paulista (UNESP)Ferreira Filho, Celso [UNIFESP]Abreu, Luiz Carlos deValenti, Vitor Engrácia [UNIFESP]Ferreira, MarceloMeneghini, AdrianoSilveira, José AlexandrePerez Riera, Andrés Ricardo [UNIFESP]Colombari, Eduardo [UNIFESP]Murad, NeifSantos-Silva, Paulo RobertoSilva, Lovian José Henrique Pereira daVanderlei, Luiz Carlos MarquesCarvalho, Tatiana Dias de [UNIFESP]Ferreira, Celso [UNIFESP]2015-06-14T13:41:24Z2015-06-14T13:41:24Z2010-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion723-728application/pdfhttp://dx.doi.org/10.1590/S1807-59322010000700012Clinics. Faculdade de Medicina / USP, v. 65, n. 7, p. 723-728, 2010.10.1590/S1807-59322010000700012S1807-59322010000700012.pdf1807-5932S1807-59322010000700012http://repositorio.unifesp.br/handle/11600/5488WOS:000280808400012engClinicsinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-06T09:48:58Zoai:repositorio.unifesp.br/:11600/5488Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-06T09:48:58Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Anti-hypertensive drugs have different effects on ventricular hypertrophy regression |
title |
Anti-hypertensive drugs have different effects on ventricular hypertrophy regression |
spellingShingle |
Anti-hypertensive drugs have different effects on ventricular hypertrophy regression Ferreira Filho, Celso [UNIFESP] Hypertrophy Cardiomyopathy Hypertrophic Left ventricle hypertension Cardiology |
title_short |
Anti-hypertensive drugs have different effects on ventricular hypertrophy regression |
title_full |
Anti-hypertensive drugs have different effects on ventricular hypertrophy regression |
title_fullStr |
Anti-hypertensive drugs have different effects on ventricular hypertrophy regression |
title_full_unstemmed |
Anti-hypertensive drugs have different effects on ventricular hypertrophy regression |
title_sort |
Anti-hypertensive drugs have different effects on ventricular hypertrophy regression |
author |
Ferreira Filho, Celso [UNIFESP] |
author_facet |
Ferreira Filho, Celso [UNIFESP] Abreu, Luiz Carlos de Valenti, Vitor Engrácia [UNIFESP] Ferreira, Marcelo Meneghini, Adriano Silveira, José Alexandre Perez Riera, Andrés Ricardo [UNIFESP] Colombari, Eduardo [UNIFESP] Murad, Neif Santos-Silva, Paulo Roberto Silva, Lovian José Henrique Pereira da Vanderlei, Luiz Carlos Marques Carvalho, Tatiana Dias de [UNIFESP] Ferreira, Celso [UNIFESP] |
author_role |
author |
author2 |
Abreu, Luiz Carlos de Valenti, Vitor Engrácia [UNIFESP] Ferreira, Marcelo Meneghini, Adriano Silveira, José Alexandre Perez Riera, Andrés Ricardo [UNIFESP] Colombari, Eduardo [UNIFESP] Murad, Neif Santos-Silva, Paulo Roberto Silva, Lovian José Henrique Pereira da Vanderlei, Luiz Carlos Marques Carvalho, Tatiana Dias de [UNIFESP] Ferreira, Celso [UNIFESP] |
author2_role |
author author author author author author author author author author author author author |
dc.contributor.none.fl_str_mv |
Faculdade de Medicina do ABC Disciplina de Cardiologia Departamento de Clínica Médica Faculdade de Medicina do ABC Departamento de Morfologia e Fisiologia Universidade Federal de São Paulo (UNIFESP) Universidade Estadual Paulista (UNESP) |
dc.contributor.author.fl_str_mv |
Ferreira Filho, Celso [UNIFESP] Abreu, Luiz Carlos de Valenti, Vitor Engrácia [UNIFESP] Ferreira, Marcelo Meneghini, Adriano Silveira, José Alexandre Perez Riera, Andrés Ricardo [UNIFESP] Colombari, Eduardo [UNIFESP] Murad, Neif Santos-Silva, Paulo Roberto Silva, Lovian José Henrique Pereira da Vanderlei, Luiz Carlos Marques Carvalho, Tatiana Dias de [UNIFESP] Ferreira, Celso [UNIFESP] |
dc.subject.por.fl_str_mv |
Hypertrophy Cardiomyopathy Hypertrophic Left ventricle hypertension Cardiology |
topic |
Hypertrophy Cardiomyopathy Hypertrophic Left ventricle hypertension Cardiology |
description |
OBJECTIVES: There is a direct relationship between the regression of left ventricular hypertrophy (LVH) and a decreased risk of mortality. This investigation aimed to describe the effects of anti-hypertensive drugs on cardiac hypertrophy through a meta-analysis of the literature. METHODS: The Medline (via PubMed), Lilacs and Scielo databases were searched using the subject keywords cardiac hypertrophy, antihypertensive and mortality. We aimed to analyze the effect of anti-hypertensive drugs on ventricle hypertrophy. RESULTS: The main drugs we described were enalapril, verapamil, nifedipine, indapamina, losartan, angiotensin-converting enzyme inhibitors and atenolol. These drugs are usually used in follow up programs, however, the studies we investigated used different protocols. Enalapril (angiotensin-converting enzyme inhibitor) and verapamil (Ca++ channel blocker) caused hypertrophy to regress in LVH rats. The effects of enalapril and nifedipine (Ca++ channel blocker) were similar. Indapamina (diuretic) had a stronger effect than enalapril, and losartan (angiotensin II receptor type 1 (AT1) receptor antagonist) produced better results than atenolol (selective β1 receptor antagonist) with respect to LVH regression. CONCLUSION: The anti-hypertensive drugs induced various degrees of hypertrophic regression. |
publishDate |
2010 |
dc.date.none.fl_str_mv |
2010-01-01 2015-06-14T13:41:24Z 2015-06-14T13:41:24Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1590/S1807-59322010000700012 Clinics. Faculdade de Medicina / USP, v. 65, n. 7, p. 723-728, 2010. 10.1590/S1807-59322010000700012 S1807-59322010000700012.pdf 1807-5932 S1807-59322010000700012 http://repositorio.unifesp.br/handle/11600/5488 WOS:000280808400012 |
url |
http://dx.doi.org/10.1590/S1807-59322010000700012 http://repositorio.unifesp.br/handle/11600/5488 |
identifier_str_mv |
Clinics. Faculdade de Medicina / USP, v. 65, n. 7, p. 723-728, 2010. 10.1590/S1807-59322010000700012 S1807-59322010000700012.pdf 1807-5932 S1807-59322010000700012 WOS:000280808400012 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Clinics |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
723-728 application/pdf |
dc.publisher.none.fl_str_mv |
Faculdade de Medicina / USP |
publisher.none.fl_str_mv |
Faculdade de Medicina / USP |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1814268405770878976 |